Molecular basis of perinatal changes in UDP-glucuronosyltransferase activity in maternal rat liver.
The molecular basis of perinatal changes occurring in major UDP-glucuronosyltransferase (UGT) family 1 isoforms and in UGT2B1, a relevant isoform belonging to family 2, was analyzed in rat liver. Nonpregnant, pregnant (19-20 days of pregnancy), and two groups of postpartum animals corresponding to early and middle stages of lactation (2-4 and 10-12 days after delivery, respectively) were studied. UGT activity determined in UDP-N-acetylglucosamine-activated microsomes revealed that bilirubin, p-nitrophenol, and ethynylestradiol (17beta-OH and 3-OH) but not androsterone and estrone glucuronidation rates, were decreased in pregnant rats. Decreased enzyme activities returned to control values after delivery. p-Nitrophenol, androsterone, and estrone conjugation rate increased in postpartum rats. Western blot analysis performed with anti-peptide-specific (anti-1A1, 1A5, 1A6, and 2B1) antibodies revealed decreased levels of all family 1 isoforms and UGT2B1 during pregnancy. In postpartum animals, protein level recovered (1A5 and 2B1) or even increased (1A1 and 1A6) with respect to control rats. Northern blot analysis suggested that expression of UGT proteins is down-regulated at a post-translational level during pregnancy and that increased levels of 1A1 and 1A6 observed in postpartum rats were associated to increased mRNA. To establish whether prolactin is involved in up-regulation of UGT1A1 and 1A6 postpartum, ovariectomized rats were treated with 300 microg of ovine prolactin per day for 7 days. The data indicated that prolactin was able to increase expression of UGT1A6 (protein and mRNA) but not 1A1. Thus, prolactin is the likely mediator of the increased expression of UGT1A6 observed in maternal liver postpartum.
Luquita
M G
MG
Institute of Experimental Physiology, School of Biochemical and Pharmaceutical Sciences, Rosario, Argentina.
Catania
V A
VA
Pozzi
E J
EJ
Veggi
L M
LM
Hoffman
T
T
Pellegrino
J M
JM
Ikushiro Si
Emi
Y
Y
Iyanagi
T
T
Vore
M
M
Mottino
A D
AD
D000818:Animals; D001663:Bilirubin / Q000378:metabolism; D004789:Enzyme Activation / Q000187:drug effects / Q000502:physiology; D004958:Estradiol / Q000378:metabolism; D004970:Estrone / Q000138:chemical synthesis / Q000378:metabolism; D005260:Female; D014453:Glucuronosyltransferase / Q000187:drug effects / Q000378:metabolism*; D007527:Isoenzymes / Q000187:drug effects / Q000378:metabolism; D008099:Liver / Q000187:drug effects / Q000201:enzymology*; D009596:Nitrophenols / Q000378:metabolism; D010052:Ovariectomy; D049590:Postpartum Period / Q000187:drug effects / Q000378:metabolism*; D011247:Pregnancy / Q000187:drug effects / Q000378:metabolism*; D011388:Prolactin / Q000494:pharmacology; D012333:RNA, Messenger / Q000187:drug effects / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D014158:Transcription, Genetic / Q000187:drug effects / Q000502:physiology; D000099148:UGT1A1 Enzyme
D001663:Bilirubin; D004958:Estradiol; D004970:Estrone; D014453:Glucuronosyltransferase; D007527:Isoenzymes; D009596:Nitrophenols; D011388:Prolactin; D012333:RNA, Messenger; D000099148:UGT1A1 Enzyme; C499946:Ugt1a1 protein, rat; C024836:4-nitrophenol